Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Tuesday, January 29, 2013

Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta...

FOLFOX and FOLFIRI are two of the most commonly used chemotherapy regimens for colorectal cancer.

http://www.drugs.com/clinical_trials/amgen-announces-results-phase-3-paves-study-evaluating-neulasta-pegfilgrastim-patients-colorectal-15098.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29

No comments:

Post a Comment

Popular Stem Cell Roundup Posts